Patents/Assignees

Novartis AG

240 patents in portfolio

US12343344utility2025
Pharmaceutical Combination Comprising TNO155 and Ribociclib
0 cites
US12344651utility2025
CD19 and CD22 Chimeric Antigen Receptors and Uses Thereof
0 cites
US12338220utility2025
Antiviral Pyrazolopiridinone Compounds
0 cites
US12338290utility2025
Regimens and Methods of Treating Multiple Sclerosis Using Ofatumumab
0 cites
US12331060utility2025
N-substituted Tetrahydrothienopyridine Derivatives and Uses Thereof
0 cites
US12331104utility2025
Hepatitis B Antibodies
0 cites
US12325870utility2025
Solubilized Apyrases, Methods and Use
0 cites
US12312353utility2025
Piperidinyl-methyl-purineamines as NSD2 Inhibitors and Anti-cancer Agents
0 cites
US12296008utility2025
Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
0 cites
US12285422utility2025
Uses of Piperidinyl-indole Derivatives
0 cites
US12280041utility2025
Compounds and Compositions for Inducing Chondrogenesis
0 cites
US12280204utility2025
Method for Measuring Flow Features in an Inhaler, Inhaler and System
0 cites
US12281125utility2025
Rapamycin Derivatives
0 cites
US12275795utility2025
Binding Molecules Against BCMA and Uses Thereof
0 cites
US12257243utility2025
5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide Derivatives for Inducing Chondrogenesis for Treating Joint Damage
0 cites
US12258680utility2025
Solid Support
0 cites
US12252478utility2025
Crystalline Forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide
0 cites
US12252479utility2025
Crystalline Forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide
0 cites
US12252482utility2025
Pyrazolopyridine Derivatives and Uses Thereof
0 cites
US12226405utility2025
Compounds and Compositions for Inhibiting the Activity of Hif2-alpha and Their Methods of Use
0 cites

← PreviousPage 4 of 12Next →